Literature DB >> 10052989

Use of "N-in-One" dosing to create an in vivo pharmacokinetics database for use in developing structure-pharmacokinetic relationships.

J E Shaffer1, K K Adkison, K Halm, K Hedeen, J Berman.   

Abstract

The purpose of this work was (1) to determine if useful in vivo pharmacokinetic data could be obtained after simultaneous administration of 5-22 compounds of a chemically congeneric series to dogs and (2) to determine if structure-pharmacokinetic relationships could be derived from such studies. Mixtures of structurally related alpha-1 antagonist compounds (5-22) were administered intravenously to conscious dogs. Blood samples were taken over the next 24 h and analyzed by LC/MS to determine plasma levels and pharmacokinetics of each compound. The pharmacokinetics of 17 of these compounds were also determined after individual administration. Results obtained in the N-in-One format for 17 compounds correlated well with results obtained when these same compounds were administered individually. The N-in-One method is a useful method for obtaining pharmacokinetic data on 5-20 molecules in a single animal at one time. The increased throughput in obtaining important pharmacokinetic information should enhance the drug discovery process. In addition, it was possible to determine the extent to which various chemical substitutions did or did not affect pharmacokinetic parameters.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10052989     DOI: 10.1021/js980292q

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries.

Authors:  Rongda Xu; Csaba Nemes; Kelly M Jenkins; Robyn A Rourick; Daniel B Kassel; Charles Z C Liu
Journal:  J Am Soc Mass Spectrom       Date:  2002-02       Impact factor: 3.109

2.  Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir.

Authors:  Erik Mogalian; Polina German; Brian P Kearney; Cheng Yong Yang; Diana Brainard; John McNally; Lisa Moorehead; Anita Mathias
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

3.  Rapid in vivo oral screening in rats: reliability, acceptance criteria, and filtering efficiency.

Authors:  Hong Mei; Walter Korfmacher; Richard Morrison
Journal:  AAPS J       Date:  2006-07-28       Impact factor: 4.009

4.  Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.

Authors:  Charu Sharma; Nihar R Biswas; Shreesh Ojha; Thirumurthy Velpandian
Journal:  Drug Des Devel Ther       Date:  2016-02-22       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.